0001209191-19-047625.txt : 20190828
0001209191-19-047625.hdr.sgml : 20190828
20190828174814
ACCESSION NUMBER: 0001209191-19-047625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190826
FILED AS OF DATE: 20190828
DATE AS OF CHANGE: 20190828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hsu Frank J.
CENTRAL INDEX KEY: 0001786723
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 191062986
MAIL ADDRESS:
STREET 1: C/O ONCTERNAL THERAPEUTICS, INC.
STREET 2: 3525 DEL MAR HEIGHTS ROAD #821
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-26
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001786723
Hsu Frank J.
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Stock Option
5.64
2019-08-26
4
A
0
150000
0.00
D
2029-08-26
Common Stock
150000
150000
D
One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
/s/ Hazel M. Aker, Attorney-in-fact
2019-08-28